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Cancer is a problem that has plagued humans our entire existence, and 
with that, has come the quest for a cure. Over many years of research we have 
discovered that the cure wasn’t easy to find and that cancer was a far more 
complicated disease than originally expected. Cancer is a disease characterized by 
uncontrolled cell growth, that begins with genetic mutations.  With advances in 
science we came to understand our genetics and then we found some potential 
causes for cancer, in our genes. It is hoped that if we can reverse the faulty 
genetic mutations that cause cancer, we may be able to cure it. The mutations 
occur in two groups of genes, oncogenes and tumor suppressor genes, and the 
latter is the focus of this paper.  
Tumor suppressor genes stop the cell cycle and can cause the cell to go 
into apoptosis, also known as programmed cell death. As the name suggests, 
these genes help prevent tumors and cancer from forming. When mutated they 
lose their function and thus their ability to prevent tumors, which can help give 
rise to cancers.  Without active tumor suppressor genes, cells can grow out of 
control, which can lead to more mutations being gained and a tumor being 
formed.  The genes I looked at are TP53, INK4, and PTEN-they have been chosen 
as they represent the range of functions tumor suppressor genes have and have 
been seen in cancers across the body. I looked at where the mutations are 
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occurring within the genes and examined potential differences between 
reproductive and nonreproductive organ-based cancers. 
Through the data I collected and the results of my analysis, I planned to 
create a dance to be performed in the Spring Dance Concert in 2020. This dance 
will be inspired by American and German theatrical Modern dance and will be an 
abstract representation of how tumor suppressors work and how they act when 
mutated. 
For my thesis, I blended art and science through the analysis of data and 
the creation of a dance. I explored how cancers and patients are affected by 
tumor suppressor genes in reproductive organ-based versus non-reproductive 
organ-based cancers. The reason behind this comparison lies in the difference in 
how the different organ system’s cells grow in terms of rate. It is hoped that a 
difference will be found and that may help understanding how cancer works. And 




Literature Review  
Cancer research has come a long way since it began, and we now 
understand that​ ​there are genes in our bodies that when mutated can contribute 
to cancer growth. With that knowledge, we have gone out to find these genes 
and see how they work, as well as what causes them to be involved in cancer. 
Although commonly grouped, tumor suppressor genes are not 
proto-oncogenes.  Though genes in both of these broad groups can cause cancer 
when they mutate, they do so in different ways.  Both sets of genes help control 
the cell cycle to regulate growth, however, tumor suppressor genes do this by 
stopping or pausing the cycle while proto-oncogenes do it by sending signals 
when they think the cell is ready to move onto the next stage. Proto-oncogenes 
are genes that check that everything the cell needs is there and if so tells the cell 
to continue to go through the cell cycle. Proto-oncogenes are called oncogenes 
when mutated and they tell the cell to just keep going through the cell cycle 
which causes quick tumor formation (Lodish, 1970). Proto-oncogenes are the 
normal non-mutated form of these genes while oncogenes are the mutated form. 
Because these two gene types function differently, their effect when mutated is 
also different.  
Tumor suppressor genes work to stop the cells of the body from dividing 
and growing out of control. They rely on outside cell signals to tell them when 
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there is space and a need to grow. They are also believed to be a possible key in 
stopping and controlling cancer. If we could unmutate these genes we could 
potentially have the body fight the cancer itself and prevent the cancer from 
coming back. To unmutate would be to return the gene to its normal functioning 
form.  This study examines the current theories on tumor suppressor genes and 
also briefly touches on what is being done in cancer research as a whole. Tumor 
suppressor genes have different subcategories: cyclin-dependent​ kinase 
inhibitors, genes that create proteins to stop the cell cycle to fix damaged DNA, 
and genes that create an enzyme to stop the cell cycle and perform apoptosis 
(programmed cell death) (Elviser, 2007). ​Tumor suppressor genes are genes that 
tell the cell cycle to stop if there is a missing factor or mutation in a gene. A 
tumor suppressor gene when mutated no longer tells the cell to stop when 
something is wrong, which can allow a proliferation of mutations.  
In an article published by the American Cancer Society, recent fields of 
interest in cancer research were presented (​Expert Predictions: Cancer Care 10 
Years From Now​, 2015).  Eight of the ten doctors mentioned DNA being used to 
treat cancer in some way. This field of using DNA for cancer treatment is called 
immunotherapy and comes out of epigenetics. Immunotherapy is a form of 
therapeutic medicine that uses knowledge of the immune system to treat the 
body. Epigenetics studies, tags that exist on genes and is a subcategory of 
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genetics. Epigenetics studies when the code of the DNA is unchanged but the 
chemical makeup and the way the DNA is read is changed. The most common 
way this happens is through methylation is the addition of a methyl group which 
causes a section of DNA to be more tightly wound making it read less often. 
Looking towards the future, many of the researchers in this article mentioned 
individualized cancer treatment. And the field of epigenetics has been working 
towards a future of individualized medicine where people would be treated with 
drugs that would turn on or off certain epigenetic factors in order to treat them. 
This is also hoped to be the future of cancer medicine if the field can figure out 
which genes are involved and what happens when they mutate, we could 
potentially undo what has gone wrong and potentially cure the patient without 
the current harm that's done through chemotherapy, radiation and the many 
drugs that come along with them (​Expert Predictions: Cancer Care 10 Years From 
Now​, 2015).  
The genes I am interested in are TP53, INK4, and PTEN, they represent the 
major functions of tumor suppressor genes. They are also present in both 
sex-organ based cancers and cancers throughout the body. They are also all being 
studied already as potentially important tumor suppressor genes. 
 ​TP53 creates protein p53 which attaches to the DNA and assesses when 
DNA is damaged, whether it can be fixed or if the cell needs to enter apoptosis. 
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Apoptosis is programmed cell death so the cell will kill itself if it recognizes that it 
is too damaged to be fixed.  If the nucleus of the cell thinks the cell can be fixed 
than the p53 will activate the proteins necessary to fix the DNA (​"TP53 Gene 
Tumor Protein p53.")  In a paper written for the National Cancer Institute the 
major research that has been done on TP53 was summarized (TP53 gene, 2020). 
There are three main factors about TP53 that allow it to contribute to cancers. 
First,  this gene can have a somatic mutation occur which has been shown to 
cause cancers. Second, TP53 in germline mutations has been found to be the 
cause of Li-Fraumeni syndrome which causes many early-onset cancers. Third, 
TP53 is highly polymorphic in its coding which means that there are many 
different forms of TP53 which increases its chance of causing cancer. A lot of the 
research that has been done has been using a human form of TP53 in mice using 
a knockout technique. A knockout is when the gene being looked at is removed 
to see what occurs when it is not there. With the amount of data we have 
gathered on TP53 we still need to do more research as we have found TP53 to 
have unique biomarkers as well as diverse forms which could make using it in 
cancer therapy difficult. What is meant by that is TP53 can shift and change and 
be hard to track due to its biomarkers so trying to find and change it for curing 
cancer could be difficult. A biomarker is a section of DNA that is suspected to 
cause a disease. 
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The purpose of the INK4 gene is to code for proteins that specifically bind 
to CDK4 and CDK6 and inhibit their activity ​ (Sherr and Roberts, 1995). The 
presence of a CDK such as 4 or 6 causes a cascade effect that allows a cell to 
move from G1 phase to S phase which moves the cell closer to being able to 
replicate, by inhibiting this activity INK4 can stop replication and DNA can be 
checked for mistakes, which lowers the risk of the cell becoming a cancer cell. 
INK4 proteins are found from early embryonic stages all the way into adulthood. 
(Zindy et. al. 1997)​. ​INK4 when mutated can cause cancer both when the protein 
made by the gene is deleted or downregulated and also when it is being 
overexpressed (The Cancer Genome Atlas Program, 2020). Both aging and stress 
have been shown to cause an increase in the expression of INK4. INK4 is also 
known to be a part of cellular processes such as apoptosis, cell invasion, and 
angiogenesis which may be the clues as to why its overexpression can cause 
cancer (Cánepa, 2007). For those cancers being caused by overexpression of 
INK4, we may be able to use it for diagnosis and as a marker of the progression of 
the cancer. On the other hand, for cancers being caused by the under-expression 
or loss of INK4 we may be able to reinsert it and use it to stop the cancer from 
growing as has been shown in a murine model. Research being done on the INK4 
gene currently involves looking at its effect in both its normal and mutated state. 
This is being done by knocking out the gene in mice, looking at gene expression in 
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a cell line, and performing genetic screens on human tumors (Roussel, 1999). 
Mice are being used both as excellent lab subjects as well as sharing 90% identity 
to the corresponding proteins that are made in humans by the INK4 gene 
(Roussel, 1999). ​It has been found that mutations in this gene are linked to a 
large percentage of sarcomas and lymphomas ​(Kamb et al., 1994; ​Ruas and 
Peters, 1998​). 
 PTEN acts as a phosphatase, which means it breaks down/removes 
phosphate groups from proteins - this is a common way that cells can send 
signals to one another. Without the phosphate group the cell is inhibited from 
migration and adhesion to other cells which is an important part of the cell cycle. 
PTEN mutations have been found to cause disorders other than cancer, including 
Cowden, Proteus, Proteus-like, and Bannayan–Riley–Ruvalcaba syndromes, as 
well as autism spectrum disorder​ (PTEN Hamartoma Tumor Syndrome, 2018). 
They have also been linked to squamous cell carcinoma of the head and neck, 
endometrial and prostate cancer, as well as Glioma 2 (GLM2), and 
Macrocephaly/autism syndrome (MCEPHAS). ​The problem that arises when 
trying to use PTEN in cancer therapy is that it undergoes complex regulation 
which makes it hard to track. PTEN has been studied quite a bit as a potential 
biomarker to track the progression of cancer (Uniport PTEN, 2020).​  Although 
pten mutations have been found in sex organs there is high expression of PTEN in 
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adult tissues of the h​eart, brain, placenta, lung, liver, muscle, kidney and 
pancreas (Steak et al 1997). 
 
Definition of terms - ​adapted from the National Human Genome Research 
Institute's ​Talking Glossary of Genetic Terms 
The most common DNA mutations occur as substitutions, deletions, or 
insertions. A ​substitution​ is when one nucleotide is switched for another, so it 
doesn’t change the number of codons but it does change which codons are 
there. ​Deletions​ are when a nucleotide is lost. ​Insertions​ are when one or more 
nucleotides are added to DNA.  A ​nucleotide​ is a single letter of DNA, this 
includes ATGC. A ​codon​ is a sequence of three nucleotides that creates a specific 
amino acid when read.  
Within those three mutations there are many consequences that can 
result. A ​frameshift ​occurs when an insertion or deletion has occurred and has 
changed the number of nucleotides, causing a shift in how the gene is read. ​Stop 
gained​ is when the codon reads as a stop before the original stop codon which 
results in a shorter protein. ​Missense​ is when a substitution occurs that causes 
the resulting amino acid to be different. ​Inframe deletion​ is when a deletion 
occurs that doesn’t change how the rest of the gene is read and results in the 
loss of amino acids. And an ​inframe insertion​ is when a section is inserted that 
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doesn’t change how the surrounding codons are read but results in more amino 
acids overall. ​3 prime UTR​ is a section of non-coding mRNA that follows after the 
stop codon, what this means as a mutation is that since this chunk is important 
for binding it can change the structure and shape of proteins. The same goes for 
a ​5 prime UTR​ though this section comes before the start codon, it regulates 
translation so when mutated that regulatory function may be lost. The ​intron​ is 
a portion of a gene that doesn’t code for a protein, usually, these are cut out in 
the translation process but sometimes they are accidentally left in. ​Start lost​ is 
when the start codon of a gene isn’t included when transcribed, which means 
that it’s unreadable as it lacks its starting point. ​Protein altering​ is a mutation 
that alters what protein is made by a gene, this consequence also means that 
none of the other mutations that could change what protein is being made have 
occurred. ​Splice mutations​ occur in the messenger RNA before translation when 
the parts needed to make the final protein are not all there, or parts are added. 
Downstream genes​ are normally activated and allow for cellular processes  like 
DNA repair, cell-cycle control and apoptosis to occur.  A mutation in a 
proto-oncogene or tumor suppressor gene can cause it to no longer activate the 
downstream genes  and is referred to as a downstream gene mutation. 
There are also many different types of tumors. ​Neoplasms​ are tumors that 
result from cells dividing when they shouldn’t be. ​Squamous cell neoplasms​ are 
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neoplasms specific to squamous cells which include the surface of the skin, the 
lining of hollow organs (bladder, kidney, and uterus), and respiratory and 
digestive tracts. A ​cystic neoplasm​ is when the tumor forms a cyst which is a sack 
with liquid on the inside. A ​serous neoplasm​ is when the tumor forms from the 
serous layer of epithelial tissue, which is what lines the outside of organs. A 
mucous neoplasm​ is when the tumor forms from the mucus lining. A ​ductural 
neoplasm​ is when the tumor forms at a duct. A ​lobular neoplasm​ is when the 
tumor forms at a lobe such as in the breast. A ​fibromatous neoplasm​ is when a 
tumor forms from connective tissue. A ​mesothelial neoplasm​ is when a tumor 
forms from the mesothelial cells which line a part of the lungs.  An ​epithelial 
neoplasm​ is when a tumor forms from epithelial cells. A ​germ cell neoplasm​ is 
when a tumor forms from germ cells also known as eggs and sperm. 
Adenomas/adenocarcinomas​ are cancers that begin in gland/secretory 
cells. ​Gliomas​ are cancers that begin in the glial cells, which are the cells that 
surround the nerves in the brain. ​Lymphomas​ are cancers that begin in the cells 
of the immune system. ​Leukemias​ are cancers that begin in blood-forming 
tissues, like bone marrow. ​Papillomas​ are cancers that begin growing on the 
tissue that lines the inside of organs and has growths that are long, and thin. 
Sarcomas​ are cancers that begin growing in bones or soft tissues.  
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Introduction 
There are two major aspects to this paper, first being the science side 
which is a metadata analysis on data from the national cancer institute on three 
tumor suppressor genes. This data is input by scientists who work in hospitals 
across the country on the genetics of people with cancer. The data is gathered in 
the hopes of finding patterns and a better understanding of how cancer forms to 
figure out how to cure it. The data includes every mutation found on a number of 
genes that may possibly be linked to cancer, which includes oncogenes and 
tumor suppressor genes.  The second aspect is the dance created from this data 
that was supposed to be showcased in the Spring Dance Concert.  
The cancer research being done right now is largely focused on gene 
mutations and trying to identify them and hopefully fix them in the future with 
CRISPR technology (American Cancer Society, 2015). The logic behind that is that 
if we can remove the cancer cells and fix the mutation, that the cancer won’t be 
able to come back as the mutation that caused it in the first place will be gone, 
also potentially removing the mutation during the treatment of cancer could stop 
cancer from growing further. This research fits within that, as a metadata analysis 
on gene mutations linked to cancer looking for patterns that may help identify 
what has gone wrong. Looking at the causes of mutations and how we may be 
able to fix those mutations. Another main aspect of the research is using tumor 
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suppressor gene protein products as biomarkers to detect cancer as well as track 
the progression of the cancer.  
But before we can do those things we need to better understand the 
genes and their mutations which my thesis aims to potentially add more 
understanding on three of the major tumor suppressor genes. The majority of my 
knowledge of this was gained through the exploration and use of a database that 
was created by the National Cancer Institute (The Cancer Genome Atlas, 2020). It 
is important to understand the causes of cancer and what things we as people 
might be doing to increase mutation rates.  Being able to understand the causes 
may lead to the cure for cancer and understanding causes of mutations may lead 
to avoidance of those things which could lower rates of cancer. 
The dance is meant to show what is happening at a microscopic level when 
cancer occurs, this is something that is hard to see and understand, and having 
an artistic representation of it is meant to be helpful. The hope is that this dance 
encourages thoughtfulness about cancer and the research that is going on about 
it. It is also meant to help those who find learning about complex scientific ideas 
by using a more accessible medium.  
Hypothesis 
I predict that sex organed based cancers will have more severe genetic 
problems in comparison to cancers located in non-sex organs. With that, I expect 
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to see more mutations in number and severity (vital status and how hard it is for 
the cell to fix). Severity implying more loci affected by the mutations, as well as 
the number of places within a loci affected and mutation consequences that 
affect more codons.  This prediction is based on the fact that the cells in sex 
based organ keep growing for the majority of one’s life, and more growth leads 
to more potential mutations to occur and accumulate.  
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Why I chose the genes I chose 
The genes I choose are representatives that are found both in 
reproductive and non-reproductive cancers. They are also widely studied genes, 
which was important for me as it allowed me to have enough data to pull from to 
have the possibility of having statistically significant findings. They also have all 
been considered as potential markers for a cancer's progression which means 
that we have been studying their importance in cancer as well as their level of 
mutation in relation to the stage of a cancer is at.  
The plan was to collect data is to input information found from the 
National Cancer Institute's GDC Data Portal. I took information on the 
location of the cancer, the number of mutations, sex affected, vital status, type of 
DNA mutation, and whether its a sex organ or not. Sex organs are invovled in 
reproduction and include ovaries, testes, breasts, the prostate gland, the vaginal 
canal, the penis, and the uterus. The location of the cancer is important in 
understanding the pattern of each of the genes and where they mutate. The 
number of mutations is important in seeing the ease at which each gene mutates, 
along with comparing the number of mutations to the vital status to see if there 
are any correlations there. The sexes affected will be listed as male/female or 
both. This database does not take into account gender or other sexes besides 
male and female, so my report will not be able to consider transgender or 
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intersex people. The vital status is whether the person with the cancer lived 
through its removal or died from the cancer. The type of DNA mutation includes 
substitution, insertion, and deletion and from those, there are several mutation 
consequences. Understanding how the mutations can form is important to 
understanding how to stop them, which is why I am including this as part of my 
research.  I included whether the cancer was in a sex organ or not, and this will 
allow me to scan my charts quickly to look at overall distribution of the data and 





The overall plan for the scientific part of my paper was to collect and enter 
my data which is outlined in the Data Collection section and then analyze that 
data as is outlined in the Data Analysis section.  
Data Collection 
I started by typing my gene of interest into the search bar of the National 
Cancer Insuites database, then I collected the data by choosing a project ID and 
then collecting data. On the main page of each project ID, I would record the vital 
status, sex, number of mutations, location, and cancer type- as well as recording 
whether that project included a sex organ-based cancer. I went into each project 
IDs mutation page and recorded the number of each type of mutation and of 
each mutation consequence. I went through and did this for every project for a 
gene and repeated it for each gene. These project IDs represent specific 
groupings of cancers and is how this database organizes its information.  
Data Analysis 
I used three programs to do my data analysis, Microsoft Excel, R which is 
an open-source statistics program, and Primer. Microsoft was mostly used as a 
place to store the data as I could turn it into the types of files the two other 
programs required. R allows for many statistical tests between two variables and 
is an easy program to make clear graphical representations. Primer allows for 
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more complex analysis with many variables through looking at things like 
resemblance between variables. Resemblance begins with you running a test that 
equalizes all of your data and then it looks at the percent difference between 
different categories.  I used an ANOVA to check to make sure all of my data is 
significantly different. I used a t-test on vital status and the number of mutations 
to look for correlation. I also used a t-test on the number of mutations between 
those found in somatic versus germline mutations.  I compared the number of 
mutations versus the number of cases with a t-test, which was meant to check 
for any sort of correlation between the number of mutations that occurred and 
the number of people affected by that cancer. This will be done as a two-sample 
unequal variance t-test. A binomial test was done for death count versus 
reproductive organ-based or not-with yes reproductive organ-based set as the 
success or 1 variable, and not reproductive organ-based set as the failure or 0 
variable. I compared which was the most common mutation consequence across 
the three genes which was done using the resemblance test in Primer. I 
compared the number of reproductive cancers across the three genes; which will 
also be done as a resemblance test in Primer. I compared vital status to mutation 
number, to check for correlation between the rate of death and rate of 
mutations. This will be done as a two-sample unequal variance t-test. This was all 
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my original plan, most of which was not accomplished due to Covid-19 which is 




Inspirations for Developing the Dance 
Modern is the basis of my technique and is a style I am inspired by. There 
are different eras of Modern where certain things came into popularity, for me 
the 1960s-70s is the era I am most inspired by. This era is identifiable by its use of 
new technology, the rebellion of older Modern styles, and chance dancing. My 
style fits within that, as I work in a very formal and minimal way as a lot of the 
choreographers of that time had.  
A large part of the inspiration for the dance I will be creating is Alwin 
Nikolais’ “Tensile Involvement”. This dance is done by a large group of dancers 
who hold ribbons that are attached to rafters on a stage. The music is 
techno-based and there is use of multicolored lights to shift the colors of both 
the costumes and ribbons. This dance was created during the second wave of 
Modern dance which occurred in the 1960s/1970s. I am most drawn to this era of 
Modern as it is highly gestural and is largely what I have been taught. The use of 
ribbons in this dance is what inspired the idea of using fabric attached to the 
costumes to create the imagery of DNA strands. I plan to have the dancers each 
grab someone else's fabric, and twist it with theirs creating a double helix image. 
Also in the particular resetting of “The Green Table” that I have seen, the side 
lighting on the dancers in blue and red which is something I would like to 
incorporate into my own dance as DNA is typically colored as blue and red. Alwin 
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Nikolais’ dances are inspired by science which is another thing that draws me to 
him as a creator. Another aspect of this era of dance that I am inspired by is the 
costumes, which were simple colored unitards that were popular at the time. I 
think unitards can do a great job of showcasing what movement is occurring 
while also obscuring and bringing the attention away from the fact that it’s a 
human on stage which can transport the dance into being less of a formal 
performance and more of an experience. These qualities are important to me in 
creating my dance.  
Another major influence on my dance is dance theater, this refers to a 
subcategory of Modern dance that includes more gesture movement and more 
use of theatrical elements. The two styles of dance theater I am most inspired by 
are German and Japanese Modern dance. Both focus on storytelling and use 
elaborate costumes and sometimes also sets and props. I plan to have a clear plot 
in my dance which is common to those styles, as well as using theatrical tools to 
add to my story rather than just adding in the visual effect as other Modern 
dance styles would do. Both German and Japanese dance theater styles use 
heavy makeup/masks which is something I am considering for my dance as I 
would like to obscure the human face to help the audience understand that the 
dancers aren’t dancers portraying genes but are instead the genes themselves. I 
also am inspired by the way slow and subtle movements are used in Japanese 
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dance theater, and my opening section for my dance was inspired by that way of 
moving. 
Thankfully, I have many other dances based on science to be inspired by, 
from the beginning of Modern dance scientific ideas have been incorporated into 
dances. And the Modern dances of the 60s/70s were heavily inspired by science, 
which may be why I am so drawn to that era of dance. Also, there is a foundation 
with a catalog of videos of turning the theses into dances ("Dance Your Ph.D"). I 
plan on watching many of those dances and reading about the processes people 
used to adapt a thesis into a dance. Dance and art in general have been used to 
explain complex ideas in ways that are easier to understand outside of the 
discipline for a very long time. Dance is a great way to represent DNA as it is 
already three dimensional and does move.  
When I think of DNA, I think of something that is so immaculately and 
beautifully designed. The way in which DNA is able to be a source of so many 
different structures with vastly different functions is incredible. I picture it as the 
perfect machine, which is why I find I was so drawn to balletic movement to 
capture DNA. Ballet is seen as this very precise, rigid, and beautiful form of dance 
which is why it felt so perfect to be the starting inspiration for how my dancers 
would move. I personally have roots in hip hop and see that as a large inspiration 
for how I want the mutated dancers to move. The classic popping and locking 
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with the sharp staccato movements is something I plan to use when creating the 
mutated version of the movement. And overall I plan to use Modern movements 





My overall concept for my dance is to show how cancer works on a 
microscopic level, with each of my dancers representing a gene within a single 
cell. An important part of cancer is mutation and I plan to show that through 
having one of my dancers begin the dance doing a mutated version of the 
choreography and slowly have the other dancers join till they are all mutated, I 
want to do it this way as it is rare to have few mutations cause cancer. Most 
cancers are caused by a combination of many mutations. A mutated movement 
to me is largely twitch movement which is something I am naturally drawn to, it 
feels chaotic and spontaneous which to me fits what a mutated gene is like. I 
want the mutated movement to be passed on in the many ways DNA mutations 
can be passed, which includes randomly without any correlation between the 
two mutation events, a mutation causing another right next to it, and mutation 
skipping down the DNA to a section farther away. I plan on using the eight 
dancers to help create the imagery of the machine that is DNA. The idea of DNA 
as a machine will be shown through hard labor like movements that lean to the 
robotic side as far as their look. I also want an even number so that when the 
dancers pair up, they can pair up evenly. I also want the dance to start in a large 
clump and then separate into smaller groups to represent the cell dividing. I 
picture it beginning with the dancers being so close together that it is hard to 
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distinguish their bodies from one another. Slowly mutations will form and 
accumulate till all the dancers are doing mutated movement and in the end, they 
form a tumor and that kills the host that will be symbolized through self and 
other mutilation based choreography (I picture this as scratching and also pulling 
at the fabric) until they finally fall all the way apart and stop moving. My 
choreography is very focused on how the structuring of the dance changes the 
meaning of the movement, and so I plan on using graphs and tables I created to 
help shape the forms I use when creating the dance.  
I plan to use colored lights and gobos (stencils put on lights, can be specific 
shapes like trees or can be abstract) to break up the human form and give the 
illusion of something that is not normally seen. Creating a knot in the fabric once 
the dancer is mutated,  will be the way to signify a change to the audience that a 
mutation has occurred. For the costume, I want a unitard that has blue and red 
fabric twisted along the front left shoulder to the right hip and then for the two 
pieces of fabric to come off the unitard so that there are two stretch bands to be 
used in the choreography.  
One of my first steps in creation is to find the music I want to use, and 
then to create a music map. A music map, sections the music into parts and has 
the number of counts in all of the parts. I then use this to decide the overall 
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structure of my dance like where the climax will go, and if there is any sort of 

















I always start my process by creating a music map that allows me to chunk 
my music into sections, making it way more manageable when working on the 
choreography. Then I figured out what I wanted my main motifs to be-these are 
the movements that are used repeatedly throughout the dance that add to the 
meaning. With my dancers in my mind, I made the first form-a windowed clump, 
meaning that they are close together but are all visible. This is where the dance 
begins, and it starts with some of the core movements that will be repeated 
throughout the dance. The dancers stay in this form for a while to set up for the 
audience what the DNA normally looks like in a cell. The dancers then form a 
circle, and then pull and stretch on each other's band to represent the replication 
of DNA. They then move to a straight line that represents the DNA being lined up 
in the center of the cell in mitosis. They pull away from each other forming two 
groups/cells as mitosis is completed. By this point in the dance, there are three 
dancers mutated and I have shown how mutations can pass themselves onto 
other genes as well as how they can occur spontaneously. I then separated the 
dancers into four groups of two representing another splitting of cells. In that 
section, in each of the pairs, one dancer is mutated and the other isn't, this is to 
show how mutated and non-mutated DNA interact. This is where I got to before 
no longer being able to hold rehearsals. 
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I found this piece of music while just listening to Spotify, and knew that it 
would be great to put a dance to. I then listened to many different renditions of 
the song and fell for the one that I ended up using. I enjoy music that has many 





Covid-19 has prevented the completion of the dance aspect of my project. 
I am unable to work with my group of dancers due to social distancing. And I am 
also unable to access the dance studios, which means I do not have a safe place 
to work. As an adult having the proper flooring for dancing is important as it 
helps protect your body and allows you to dance for longer. Also having access to 
the mirrors in the dance space is important, as it allows one to quickly adjust and 
edit the choreography being created as you can see yourself. This dance was also 
built to be for a group, with having lifts and partnering which would have been 
difficult to try and transfer to a solo. So instead of attempting to fit it to a solo the 
dance has been left as is, and in the future I would like to revisit and finish it. 
With the scientific aspect of my thesis, trying to use the data software is a 
bit of a challenge as I only have access to a laptop and the number of things 
needed to run it puts enough strain that it slows the computer. It also is now 
much harder to get help and be able to get quick responses to questions that 
come up while doing statistics.  Though I was able to create my data sheets and 
fill them with all the information I thought might be necessary. I was also able to 
do the resemblance testing and set up for Primer. I also tried using some of the 
other testing functions of Primer with my data set. I also did some test t-tests in 
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excel and looked over the results of those tests to think about how I would want 
to continue to analyze the data. 
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What would have occurred  
If Covid-19 had not occurred I would have finished my dance and it would 
have been performed at the Spring Dance Concert. A recording of the dance 
would have been made and would have been linked to my thesis. I would have 
written about how the dance had turned out and how I felt about its outcome. I 
would have written about what I might have changed if I had the opportunity to 
in retrospect.  I would have also included the final lighting design and color 
references. A picture of the final costume would have been included. As well as 
the description of the dance included in the pamphlet from the concert. I would 
have also discussed the feedback from the audience as well as from other 
dancers.  
I would have also been able to finish the scientific aspect of my paper 
which would have included completing my scientific analysis. Using the results to 
draw conclusions based on my hypothesis. I would have written a results section 
outlining the results and their scientific significance and then would have drawn 
conclusions from them. I would have created graphs and tables to help with the 
visualization of my project and those would have been included in my thesis. The 
graphs and tables made may have also been used to influence the dance either 
through floor formations or lighting.   
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Appendix 
TP53 Spreadsheet 
https://docs.google.com/spreadsheets/d/e/2PACX-1vQQS2BULqc09Uoc3c2uMk
DZzuN5LHubpUdbqJFr39OMpos8Qv8gVefNN_TIhfSt8AnHCYvVRQ9M4Vs0/pubht
ml 
PTEN Spreadsheet 
https://docs.google.com/spreadsheets/d/e/2PACX-1vQ-vPhlifLYsYhu2BzJyb0Q2v
3XizfTi5ppZNHFap0elilcOkSMFIemlxXbW3l79kw60lklxIBAYMLU/pubhtml 
INK4 Spreadsheet 
https://docs.google.com/spreadsheets/d/e/2PACX-1vQZYDli6NTG_Bej8k2p71gHS
bV2bo1xpX0wQO9QbhWLORSxA3E-rvRWDoQKqaw-U5HJXI4Xn99dqGHY/pubhtm
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